Skip to main content

Find Clinical Trials

Home
Conditions
Large B-Cell Lymphoma (LBCL)

Clinical trial condition

Large B-Cell Lymphoma (LBCL)

Explore clinical trials studying Large B-Cell Lymphoma (LBCL). Study availability and eligibility vary by location and protocol.

13 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Large B-Cell Lymphoma (LBCL) trial results

Not yet recruiting

Exploratory Clinical Study on the Safety and Efficacy of CD19X CAR-T Cell Injection in the Treatment of Relapsed/Refractory Large B-Cell Lymphoma

NCT07447726

Conditions: Disease Attributes, Large B-Cell Lymphoma (LBCL), Pathologic Processes, +2 more
Locations: Not specified

View Trial Details

Not yet recruiting

Golcadomide, Poseltinib, and Rituximab for Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT07269639

Conditions: Large B-Cell Lymphoma (LBCL)
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Active, not recruiting

CD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cell Lymphoma

NCT07461831

Conditions: Large B-Cell Lymphoma (LBCL)
Locations: Beijing Tongren Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details